The future facility will also house a state-of-the-art R&D pilot plant to manufacture medicines for clinical trials. As a ...

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US. The programme represents the largest capital spend by ...

GSK launched Shingrix in China in 2020. Meanwhile, the company is also investing in additional manufacturing capacity to meet the expected demand, with a new plant due to come online in 2024.

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

In a bid to help the immune system of autoimmune disease patients reset, a San Francisco startup startup has raised $120 ...

Lacalle Pou “welcomed GSK's announcement of the opening of one ... will concentrate the products manufactured in its different plants in Europe. Nevertheless, the agreement between GSK and ...

for six of GSK's most prescribed medicines in the UAE. This first batch includes 35 thousand packages of medicine, which have been manufactured at Neopharma's manufacturing plant in Abu Dhabi ...

Drugs giant GlaxoSmithKline (GSK) is launching a development plan that is set to create up to 5,000 new jobs. The company is looking to extend its facility in Stevenage, Hertfordshire, where it ...

GSK has also advanced vaccine collaborations, including adjuvanted protein-based candidate vaccines with Sanofi and SK bioscience, the adjuvanted plant-based vaccine with Medicago, and next ...